Interdisciplinary and multiprofessional outpatient secondary individual prevention of work-related skin diseases in the metalworking industry: 1-year follow-up of a patient cohort [0.03%]
职业性皮肤病的跨学科和多专业门诊二级个体预防：金属加工业患者队列1年随访研究
Annika Wilke,Günther Gediga,Andreas Goergens et al.
Annika Wilke et al.
Background: In Germany, work-related skin diseases are predominant within the spectrum of reported occupational diseases. Metal workers are among the high-risk professions. Offering effective prevention programs to affect...
Observational Study
BMC dermatology. 2018 Dec 12;18(1):12. DOI:10.1186/s12895-018-0080-2 2018
Assessing skin disease and associated health-related quality of life in a rural Lao community [0.03%]
老挝农村社区皮肤疾病及其相关生活质量的评估
C I Wootton,S Bell,A Philavanh et al.
C I Wootton et al.
Background: Skin diseases are common and often have an impact on an individual's health-related quality of life. In rural communities where access to healthcare may be limited and individuals rely on farming for food and ...
Exploratory study of the reproducibility of the SCore for INtrinsic and EXtrinsic skin aging (SCINEXA) scale in "Ruta Escondida de la Mitad del Mundo", Ecuador, 2017 [0.03%]
厄瓜多尔SCINEXA量表在“Mitad del Mundo的隐藏之路”地区再现性探索性研究，2017年
Martha Fors,Santiago Palacios,Kirsten Falcon et al.
Martha Fors et al.
Background: Few studies have been published related to the analysis of different skin aging parameters for whole-body skin using the SCINEXA scale for skin damage. The aim of this study was to evaluate the reproducibility...
Observational Study
BMC dermatology. 2018 Nov 6;18(1):10. DOI:10.1186/s12895-018-0078-9 2018
Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink [0.03%]
针对特应性皮炎患儿及成人患者开具保湿剂药方的成本和有效性：Clinical Practice Research Datalink的大规模回顾性分析
George Moncrieff,Annie Lied-Lied,Gill Nelson et al.
George Moncrieff et al.
Background: The Clinical Practice Research Datalink (CPRD) was used to evaluate the overall costs to the National Health Service, including healthcare utilisation, of prescribing emollients in UK primary care for dry skin...
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report [0.03%]
奥马珠单抗治疗荨麻疹性血管炎患者的预后报告：病例报告
Ivan Cherrez-Ojeda,Emanuel Vanegas,Miguel Felix et al.
Ivan Cherrez-Ojeda et al.
Background: Despite the current knowledge of UV, there is a lack of consensus among diagnostic criteria and management. In general, antihistamine therapy is regularly used for the symptomatic management of pruritus but do...
Case Reports
BMC dermatology. 2018 Oct 25;18(1):8. DOI:10.1186/s12895-018-0077-x 2018
Acne in Lomé, Togo: clinical aspects and quality of life of patients [0.03%]
多哥洛美地区的痤疮患者的临床特点和生活质量研究
Bayaki Saka,Abla Séfako Akakpo,Julienne Noude Téclessou et al.
Bayaki Saka et al.
Background: Acne is a chronic inflammatory condition affecting the pilosebaceous follicle that mainly affects adolescents and young adults. The aim of this study was to assess the quality of life (QOL) of patients with ac...
Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India) [0.03%]
印度头癣共识(ECTODERM印度)
Murlidhar Rajagopalan,Arun Inamadar,Asit Mittal et al.
Murlidhar Rajagopalan et al.
Background: Dermatophytosis management has become an important public health issue, with a large void in research in the area of disease pathophysiology and management. Current treatment recommendations appear to lose the...
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database [0.03%]
日本生物制剂治疗银屑病的持续率和医疗费用的真实世界数据研究
Rosarin Sruamsiri,Kosuke Iwasaki,Wentao Tang et al.
Rosarin Sruamsiri et al.
Background: Biological therapies (BTs) including infliximab (IFX), adalimumab (ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment of psoriasis. Although the persistence rates and medical...
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization [0.03%]
美国成人中度至重度银屑病患者的现实世界健康结局：利用电子健康记录数据研究患者感知的治疗效果、药物使用和医疗资源利用率的研究性人口研究
April W Armstrong,Shonda A Foster,Brian S Comer et al.
April W Armstrong et al.
Background: Little is known regarding real-world health outcomes data among US psoriasis patients, but electronic health records (EHR) that collect structured data at point-of-care may provide opportunities to investigate...
Observational Study
BMC dermatology. 2018 Jun 28;18(1):4. DOI:10.1186/s12895-018-0072-2 2018
Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial [0.03%]
一种支持银屑病患者的APP能改善局部治疗的依从性吗？一项单盲随机对照试验
Mathias Tiedemann Svendsen,Flemming Andersen,Kirsten Hammond Andersen et al.
Mathias Tiedemann Svendsen et al.
Background: Topical corticosteroid or corticosteroid/calcipotriol preparations are recommended first-line topical treatments of psoriasis, but a main cause for the lack of efficacy of topical treatments is considered low ...
Randomized Controlled Trial
BMC dermatology. 2018 Feb 7;18(1):2. DOI:10.1186/s12895-018-0071-3 2018